Skip to main content
Log in

Identification, Synthesis, and Characterization of Potential Dichloro Impurity: N,N-Dimethyl-3-Phenyl-2, 3-Dichloropropylamine in the Synthesis of Atomoxetine

  • STRUCTURE OF CHEMICAL COMPOUNDS, METHODS OF ANALYSIS, AND PROCESS CONTROL
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

An unknown impurity was identified using the HPLC technique at relative retention time ~1.07 with a peak area of 0.45% during the commercial synthesis of atomoxetine. The profile of the new impurity was established using 1H NMR and LCMS spectroscopy and found to be N,N-dimethyl-3-phenyl-2,3-dichloropropylamine. Adetailed analysis was made using different experimental techniques to find the cause of dichloro impurity. It has been recognized that thionyl chloride (SOCl2) was the potential cause of the formation of the dichloro impurity. The mechanism of the formation of the impurity using retrosynthetic analysis and synthetic strategy was also discussed. The synthesized impurity was compared with the formed impurity by employing LCMS, IR, and NMR spectroscopy. Astrategy for minimizing this potential dichloro impurity was discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.

Similar content being viewed by others

References

  1. Z. Ye, E. Altena, C. Nombela, et al., Biol. Psychiatry, 77(8), 740–748 (2015); https://doi.org/10.1016/j.biopsych.2014.01.024.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. J. M. Sauer, B. J. Ring, J. W. Witcher, Clin. Pharmacokinetics, 44(6), 571–590 (2005); https://doi.org/10.2165/00003088-200544060-00002.

  3. F. Bymaster, Neuropsychopharmacology, 27(5), 699–711 (2002); https://doi.org/10.1016/S0893-133X(02)00346-9.

  4. J. H. Heiligenstein, D. Gary, J. Urology, et al., Patent US 5,658,590 (1997).

  5. B. M. Bryan, K. K. Schmiegel, Patent US 4,314,081 (1982).

  6. B. M Bryan, K. K. Schmiegel, Eli Lilly and Company, Patent US 4003160A (1977).

  7. R. Saputra, J. Chem. Inf. Model., 53, 1689–1699 (1984).

    Google Scholar 

  8. I. Khairoun, R. Z. Legeros, G. Daculsi, et al., European Patent 1761472B1 (2007).

  9. E. Castelli, A. Vailati, Patent US 7378553B2 (2008).

  10. J. M. Krasniewski, M. W. Mosher, J. Org. Chem., 39(9), 1303–1306 (2002); https://doi.org/10.1021/jo00923a030.

  11. Srinivasan, Chidambaram, Venkateswaran, et al., International Publication No. WO 2009/141833 A2 (2009).

  12. N. Lopez, J. Gomez-Segura, R. P. Marin, J. Perez-Ramirez, J. Catal., 255(1), 29–39 (2008); https://doi.org/10.1016/.jcat.2008.01.020.

  13. L. Friedman, W. P. Wetter, J. Chem. Soc. A: Inorg., Phys. Theor., 36 – 37 (1967); https://doi.org/10.1039/j19670000036.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karteek Rao Amperayani.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pinninti, S.K., Tene, S., T, S.R. et al. Identification, Synthesis, and Characterization of Potential Dichloro Impurity: N,N-Dimethyl-3-Phenyl-2, 3-Dichloropropylamine in the Synthesis of Atomoxetine. Pharm Chem J 57, 1304–1313 (2023). https://doi.org/10.1007/s11094-024-03039-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-024-03039-8

Keywords

Navigation